Intravenous Stem Cells After Ischemic Stroke "ISIS"


Phase 2 Results N/A

Summary of Purpose

The main objective of the study is to evaluate feasibility and tolerance of the intravenous injection of autologous mesenchymal stem cells for patients presenting an ischemic stroke (less than 6 weeks).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 October 2017.

1 Aug 2010 2 Apr 2009 20 Oct 2017 20 Oct 2017 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment